Back

The discriminative power and optimal diagnostic thresholds of NT-proBNP in patients admitted with acute heart failure-related signs and symptoms: a prospective observational study

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Rapid Fire 3 - Acute heart failure Biomarkers HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Panagiotis Simitsis

Attikon University Hospital, Athens (Greece)

9 More presentations in this session

Presentation thumbnail
Compeering of predictive accuracy for 30, 90 and 365-day Heart Failure readmission assessed by impedance technique and NT-proBNP. Results of IMPEDANCE-HF extended trial
Professor M. Kleiner Shochat (Hadera, IL)
Abstract Slides Video
Presentation thumbnail
Improving diuresis and dropsy with elamipretide in advanced heart failure (IDDEA-HF); a multi-centre, double-blind, placebo-controlled trial
Professor J. Cleland (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
BIS equation of glomerular filtration rate in the prediction of hospitalization and mortality in older patients with heart failure
Doctor J. Santos (Viseu, PT)
Abstract Slides Video
Presentation thumbnail
Incident hyperkalemia and RAAS-inhibition during an acute heart failure hospitalization
Mr J. Beusekamp (Groningen, NL)
Abstract
Presentation thumbnail
Concurrent Initiation of Intra-aortic Balloon Pumping with Extracorporeal Membrane Oxygenation Reduced In-hospital Mortality in Postcardiotomy Cardiogenic Shock
Doctor K. Chen (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Rapid Fire 3 - Acute heart failure

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019
You may be interested in
thumbnail
Congress Presentation
The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure
thumbnail
Congress Presentation
Novel concepts in the diagnosis of AHF in the emergency department
thumbnail
Congress Presentation
Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources